Continued Strong Results in Q2 FY 24 5 Q2 FY 24 Sales Drivers 50 PACK ORIGINAL Dual Action: Second Quarter FY 2024 Results November 2吋, 2023 I. Performance Update S E C O N D Q U A R T E R F Y 2 4 R E S U L T S eve ◼ Solid quarterly Revenue of $286.3 million, similar to prior year's record level ◼ Consumers continue to seek the benefits of trusted consumer healthcare brands ◼ Continue to benefit from leading & diversified portfolio ◼ Gross Margin as expected with sequential improvement ◼ Solid financial pro ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to _____ PRESTIGE CONSUMER HEALTHCARE INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Or ...

Prestige Consumer Healthcare Inc. (NYSE:PBH) Q1 2024 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Phil Terpolilli - VP, IR and Treasury Ron Lombardi - CEO Christine Sacco - CFO Conference Call Participants Susan Anderson - Canaccord Genuity Rupesh Parikh - Oppenheimer & Co Jon Andersen - William Blair Mitchell Pinheiro - Sturdivant & Co. Operator Good day and thank you for standing by. Welcome to the Q1 2024 Prestige Consumer Healthcare, Inc. Earnings Conference Call. At this time ...

RIPLE CLEAN O Safe Harbor Disclosure F I R S T Q U A R T E R F Y 2 4 R E S U L T S I. Performance Update F I R S T Q U A R T E R F Y 2 4 R E S U L T S Business Momentum Continued in First Quarter FY 24 ◼ Continued strong performance enabled by benefits of leading & diversified portfolio 50 rac Prestige Consumer HEALTHCARE ULTIMATE All adjusted GAAP numbers presented are footnoted and reconciled to their closest GAAP measurement in the attached reconciliation schedule or in our August 3, 2023 earnings releas ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to _____ PRESTIGE CONSUMER HEALTHCARE INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organiz ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ______ TO ______ Commission File Number: 001-32433 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2023 PRESTIGE CONSUMER HEALTHCARE INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Inco ...

Prestige Consumer Healthcare Inc. (NYSE:PBH) Q3 2023 Results Conference Call February 2, 2023 8:30 AM ET Company Participants Phil Terpolilli - Vice President of Investor Relations & Treasurer Ronald Lombardi - President and Chief Executive Officer Christine Sacco - Chief Financial Officer Conference Call Participants Susan Anderson - Canaccord Genuity Rupesh Parikh - Oppenheimer and Company Jon Andersen - William Blair Mitchell Pinheiro - Sturdivant & Co Linda Bolton Weiser - D.A. Davidson Operator Good da ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to _____ Commission File Number: 001-32433 PRESTIGE CONSUMER HEALTHCARE INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Ju ...

50 race ENSITIVE EYES Second Quarter FY 2023 Results November 3吋, 2022 RIPLE CLEAN 0 ULTIMATE Prestige Consumer HEALTHCARE Safe Harbor Disclosure This presentation contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding the Company's expected financial performance, including revenues, diluted EPS, leverage, free cash flow, and organic revenue growth; the Company's ability to execute on its brand-building strategy; ...

Prestige Consumer Healthcare Inc. (NYSE:PBH) Q2 2023 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations and Treasurer Ron Lombardi - President and Chief Executive Officer Christine Sacco - Chief Financial Officer Conference Call Participants Rupesh Parikh - Oppenheimer & Co. Jon Andersen - William Blair Operator Good day and thank you for standing by. Welcome to the Prestige Consumer Healthcare Second Quarter Earnings Conference Cal ...